Cargando…
Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
OBJECTIVE: To assess the cost-effectiveness of six treatment strategies for patients diagnosed with recurrent Clostridium difficile infection (CDI) in Canada: 1. oral metronidazole; 2. oral vancomycin; 3.oral fidaxomicin; 4. fecal transplantation by enema; 5. fecal transplantation by nasogastric tub...
Autores principales: | Lapointe-Shaw, Lauren, Tran, Kim L., Coyte, Peter C., Hancock-Howard, Rebecca L., Powis, Jeff, Poutanen, Susan M., Hota, Susy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769325/ https://www.ncbi.nlm.nih.gov/pubmed/26901316 http://dx.doi.org/10.1371/journal.pone.0149521 |
Ejemplares similares
-
Is a Single Fecal Microbiota Transplant a Promising Treatment for Recurrent Clostridium difficile Infection?
por: Hota, Susy S, et al.
Publicado: (2018) -
Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study
por: Leis, Jerome A, et al.
Publicado: (2013) -
Determining Mortality Rates Attributable to Clostridium difficile Infection
por: Hota, Susy S., et al.
Publicado: (2012) -
A microbial consortium alters intestinal Pseudomonadota and antimicrobial resistance genes in individuals with recurrent Clostridioides difficile infection
por: Rooney, Ashley M., et al.
Publicado: (2023) -
Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)